You are viewing an incomplete version of our website. Please click to reload the website as full version.

anti-Cynomolgus p53 antibody for ELISA

Recommended p53 Antibody (supplied by: Log in to see )

Antigen
Tumor Protein P53 (TP53) Antibodies
  • bbl
  • BCC7
  • bfy
  • bhy
  • brp53
  • drp53
  • etID22686.5
  • fb40d06
  • LFS1
  • p44
  • P53
  • p53
  • tp53
  • TP53
  • Tp53
  • TpMs
  • Trp53
  • TRP53
  • wu:fb40d06
  • Xp53
  • zgc:111919
Epitope
AA 1-393
123
87
62
54
51
50
49
48
46
46
43
40
39
30
27
25
22
20
19
17
17
13
13
13
13
13
12
11
9
9
9
8
8
8
8
8
8
8
7
7
7
6
6
6
6
6
6
6
6
5
5
5
5
5
4
4
4
4
4
4
4
4
4
4
4
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
Reactivity
Cynomolgus
1761
319
269
99
34
19
13
11
11
10
10
9
5
4
4
3
3
3
3
2
2
2
1
Host
Mouse
1235
612
7
4
3
1
1
Clonality
Monoclonal
Conjugate
This p53 antibody is un-conjugated
59
49
34
31
23
23
15
15
14
14
14
14
14
14
13
4
4
4
4
4
4
4
4
4
4
3
1
1
Minimum Detection Limit
0.078 ng/well
Application
ELISA, Western Blotting (WB)
1378
581
529
319
315
303
235
156
99
87
53
39
35
17
16
12
12
11
11
9
4
3
3
3
2
2
2
1
1
1
1
1
Supplier
Log in to see
Supplier Product No.
Log in to see
Request

Get this product for free

It's quick and easy to submit your validation proposal. I want to validate this product

Learn more

Available images

Catalog No. ABIN2001729
$ 218.90
Plus shipping costs $45.00
Relevance Score ABIN Application Conjugate Host Isotype Epitope Supplier Clonality References Details
0.0012052363 ABIN2001735 ELISA Rabbit IgG AA 1-393 Log in to see Polyclonal 3
0.0012052363 ABIN2001733 ELISA Rabbit IgG AA 1-393 Log in to see 14

Top referenced anti-p53 antibody for ELISA

Similar anti-p53 Antibodies

Application / Reactivity Cynomolgus
ELISA 3 Antibodies
Immunofluorescence (IF) 1 Antibodies
Immunohistochemistry (Paraffin-embedded Sections) (IHC (p)) 1 Antibodies
Western Blotting (WB) 1 Antibodies

General

Antigen Tumor Protein P53 (TP53) Antibodies
Epitope AA 1-393
(123), (87), (62), (54), (51), (50), (49), (48), (46), (46), (43), (40), (39), (30), (27), (25), (22), (20), (19), (17), (17), (13), (13), (13), (13), (13), (12), (11), (9), (9), (9), (8), (8), (8), (8), (8), (8), (8), (7), (7), (7), (6), (6), (6), (6), (6), (6), (6), (6), (5), (5), (5), (5), (5), (4), (4), (4), (4), (4), (4), (4), (4), (4), (4), (4), (3), (3), (3), (3), (3), (3), (3), (3), (3), (3), (3), (3), (3), (3), (3), (3), (3), (3), (3), (3), (3), (2), (2), (2), (2), (2), (2), (2), (2), (2), (2), (2), (2), (2), (2), (2), (2), (2), (2), (2), (2), (2), (2), (2), (2), (1), (1), (1), (1), (1), (1), (1), (1), (1), (1), (1), (1), (1), (1), (1), (1), (1), (1), (1), (1), (1), (1), (1), (1), (1), (1), (1), (1), (1), (1), (1), (1), (1), (1), (1), (1), (1), (1), (1), (1), (1), (1), (1), (1), (1), (1), (1), (1), (1), (1), (1), (1), (1), (1), (1), (1), (1), (1), (1), (1), (1), (1), (1), (1), (1), (1), (1), (1), (1), (1), (1)
Reactivity Cynomolgus
(1761), (319), (269), (99), (34), (19), (13), (11), (11), (10), (10), (9), (5), (4), (4), (3), (3), (3), (3), (2), (2), (2), (1)
Host Mouse
(1235), (612), (7), (4), (3), (1), (1)
Clonality (Clone)
Monoclonal   ( )
Conjugate This p53 antibody is un-conjugated
(59), (49), (34), (31), (23), (23), (15), (15), (14), (14), (14), (14), (14), (14), (13), (4), (4), (4), (4), (4), (4), (4), (4), (4), (4), (3), (1), (1)
Minimum Detection Limit 0.078 ng/well
Application ELISA, Western Blotting (WB)
(1378), (581), (529), (319), (315), (303), (235), (156), (99), (87), (53), (39), (35), (17), (16), (12), (12), (11), (11), (9), (4), (3), (3), (3), (2), (2), (2), (1), (1), (1), (1), (1)
Pubmed 6 references available
Supplier Log in to see

Product Details anti-p53 Antibody

Target Details p53 Application Details Handling References for anti-p53 Antibody (ABIN2001729) Images
Specificity Cynomolgus p53 / TP53
Cross-Reactivity (Details) No cross-reactivity in ELISA with E.coli cell lysate
Characteristics This antibody was produced from a hybridoma resulting from the fusion of a mouse myeloma with B cells obtained from a mouse immunized with purified, recombinant Cynomolgus p53 / TP53 (rC p53 / TP53, E3U906, Met 1-Asp 393). The IgG fraction of the cell culture supernatant was purified by Protein A affinity chromatography.
Purification Affinity Purified
Sterility 0.2 μm filtered
Clone 6
Isotype IgG1

Target Details p53

Product Details anti-p53 Antibody Application Details Handling References for anti-p53 Antibody (ABIN2001729) Images back to top
Antigen
Alternative Name TP53 (TP53 Antibody Abstract)
Background P53, also known as Tp53, is a DNA-binding protein which belongs to the p53 family. It contains transcription activation, DNA-binding, and oligomerization domains. p53 protein is expressed at low level in normal cells and at a high level in a variety of transformed cell lines, where it's believed to contribute to transformation and malignancy. p53 (TP53) is a transcription factor whose protein levels and post-translational modification state alter in response to cellular stress (such as DNA damage, hypoxia, spindle damage). Activation of p53 begins through a number of mechanisms including phosphorylation by ATM, ATR, Chk1 and MAPKs. MDM2 is a ubiquitn ligase that binds p53 and targets p53 for proteasomal degradation. Phosphorylation, p14ARF and USP7 prevent MDM2-p53 interactions, leading to an increase in stable p53 tetramers in the cytoplasm. Further modifications such as methylation and acetylation lead to an increase in Tp53 binding to gene specific response elements. Tp53 regulates a large number of genes (>100 genes) that control a number of key tumor suppressing functions such as cell cycle arrest, DNA repair, senescence and apoptosis. Whilst the activation of p53 often leads to apoptosis, p53 inactivation facilitates tumor progression. It is postulated to bind to a p53- binding site and activate expression of downstream genes that inhibit growth and/or invasion, and thus function as a tumor suppressor. Mutants of p53 that frequently occur in a number of different human cancers fail to bind the consensus DNA binding site, and hence cause the loss of tumor suppressor activity. Defects in TP53 are a cause of esophageal cancer, Li-Fraumeni syndrome, lung cancer and adrenocortical carcinoma.
UniProt E3U906
Pathways p53 Signaling, MAPK Signaling, PI3K-Akt Signaling, Apoptosis, AMPK Signaling

Application Details

Product Details anti-p53 Antibody Target Details p53 Handling References for anti-p53 Antibody (ABIN2001729) Images back to top
Application Notes ELISA ELISA: 0.5-1 μg/mL This antibody can be used at 0.5-1 μg/mL with the appropriate secondary reagents to detect Cynomolgus P53. The detection limit for Cynomolgus P53 is approximately 0.078 ng/well.
Restrictions For Research Use only

Handling

Product Details anti-p53 Antibody Target Details p53 Application Details References for anti-p53 Antibody (ABIN2001729) Images back to top
Buffer PBS with 5% trehalose
Preservative Without preservative
Handling Advice Avoid repeated freeze-thaw cycles.
Storage 4 °C/-20 °C/-80 °C
Storage Comment This antibody can be stored at 2°C-8°C for one month without detectable loss of activity. Antibody products are stable for twelve months from date of receipt when stored at -20°C to -70°C. Preservative-Free. Sodium azide is recommended to avoid contamination (final concentration 0.05%-0.1%). It is toxic to cells and should be disposed of properly.
Expiry Date 12 months

References for anti-p53 Antibody (ABIN2001729)

Product Details anti-p53 Antibody Target Details p53 Application Details Handling Images back to top
Background publications

Kurzhals, Titen, Xie, Golic: "Chk2 and p53 are haploinsufficient with dependent and independent functions to eliminate cells after telomere loss." in: PLoS genetics, Vol. 7, Issue 6, pp. e1002103, 2011

Pardi, Vámos, Ujfaludi, Komonyi, Bodai, Boros: "In vivo effects of abolishing the single canonical sumoylation site in the C-terminal region of Drosophila p53." in: Acta biologica Hungarica, Vol. 62, Issue 4, pp. 397-412, 2011

Wells, Johnston: "Maintenance of imaginal disc plasticity and regenerative potential in Drosophila by p53." in: Developmental biology, Vol. 361, Issue 2, pp. 263-76, 2011

Kurzhals, Titen, Xie, Golic: "Chk2 and p53 are haploinsufficient with dependent and independent functions to eliminate cells after telomere loss." in: PLoS genetics, Vol. 7, Issue 6, pp. e1002103, 2011

Pardi, Vámos, Ujfaludi, Komonyi, Bodai, Boros: "In vivo effects of abolishing the single canonical sumoylation site in the C-terminal region of Drosophila p53." in: Acta biologica Hungarica, Vol. 62, Issue 4, pp. 397-412, 2011

Wells, Johnston: "Maintenance of imaginal disc plasticity and regenerative potential in Drosophila by p53." in: Developmental biology, Vol. 361, Issue 2, pp. 263-76, 2011

Images

Product Details anti-p53 Antibody Target Details p53 Application Details Handling References for anti-p53 Antibody (ABIN2001729) back to top
Supplier Images
Western Blotting (WB) image for anti-p53 antibody (Tumor Protein P53) (AA 1-393) (ABIN2001729) anti-Tumor Protein P53 (TP53) (AA 1-393) antibody